Search

Author/Creator Lee, J J

1. 1928PPathologic assessment following neoadjuvant immunotherapy or chemotherapy demonstrates similar patterns in non-small cell lung cancer (NSCLC). (23rd October 2018)

Authors:
Weissferdt, A; Sepesi, B; Pataer, A; Kalhor, N; Moran, C A; William, W N; Le, X; Glisson, B; Skoulidis, F; Blumenschein, G; Zhang, J; Altan, M; Rice, D; Mehran, R; Lee, J J; Vaporciyan, A; Gibbons, D L; Swisher, S G; Heymach, J V; Cascone, T
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. LBA49Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC). (23rd October 2018)

Authors:
Cascone, T; William, W N; Weissferdt, A; Leung, C H; Federico, L; Haymaker, C; Bernatchez, C; Fossella, F V; Mott, F E; Papadimitrakopoulou, V A; Byers, L; Lam, V K; Godoy, M C; Carter, B; Lee, J J; Vaporciyan, A; Gibbons, D L; Swisher, S G; Heymach, J V; Sepesi, B
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma. (31st December 2018)

Authors:
Haddad, R I; Massarelli, E; Lee, J J; Lin, H Y; Hutcheson, K; Lewis, J; Garden, A S; Blumenschein, G R; William, W N; Pharaon, R R; Tishler, R B; Glisson, B S; Pickering, C; Gold, K A; Johnson, F M; Rabinowits, G; Ginsberg, L E; Williams, M D; Myers, J; Kies, M S
Journal:
Annals of oncology
Issue:
Volume 30:Number 3(2019)
Page Start:
471
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗